[1]
P. Farahani, “LACK OF HEALTH-RELATED QUALITY OF LIFE AND PATIENT-CENTRED OUTCOME MEASURES IN RANDOMIZED CONTROLLED TRIALS CONDUCTED FOR DIABETES PHARMACOTHERAPY: SGLT-2 RECEPTOR INHIBITORS AS AN EXAMPLE”, J Popl Ther Clin Pharmacol, vol. 24, no. 1, Oct. 2018, Accessed: Nov. 19, 2024. [Online]. Available: https://mail.jptcp.com/index.php/jptcp/article/view/132